Vertex Pharmaceuticals
VRTX
#177
Rank
S$153.26 B
Marketcap
S$597.76
Share price
-1.22%
Change (1 day)
-5.37%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): S$5.84 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are S$11.72 Billion. In 2024 the company made an earning of S$0.35 Billion a decrease over its 2023 earnings that were of S$5.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$5.84 B1547.34%
2024 S$0.35 B-93.69%
2023 S$5.62 B3.19%
2022 S$5.45 B53.56%
2021 S$3.55 B-12.06%
2020 S$4.03 B118.45%
2019 S$1.84 B120.64%
2018 S$0.83 B1473.64%
2017 S$53.25 M197.6%
2016 S$17.89 M-102.97%
2015 -S$0.61 Billion-28.46%
2014 -S$0.85 Billion-51.5%
2013 -S$1.74 Billion-30584.68%
2012 S$5.69 M-95.47%
2011 S$0.12 B
2009 -S$0.76 Billion
2007 -S$0.53 Billion83.1%
2006 -S$0.29 Billion59.02%
2005 -S$0.19 Billion3.28%
2004 -S$0.18 Billion-38.16%
2003 -S$0.29 Billion
2000 -S$48.4 Million-20.38%
1999 -S$60.78 Million31.62%
1998 -S$46.18 Million91.05%
1997 -S$24.17 Million-36.24%
1996 -S$37.91 Million12.45%
1995 -S$33.72 Million27.4%
1994 -S$26.46 Million-1833.33%
1993 S$1.52 M-112.12%
1992 -S$12.6 Million175%
1991 -S$4.58 Million-12.2%
1990 -S$5.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.21 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.11 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.57 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.37 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.21 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-S$96.52 Million-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA